These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32543949)

  • 21. An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder.
    Otto MW; Tuby KS; Gould RA; McLean RY; Pollack MH
    Am J Psychiatry; 2001 Dec; 158(12):1989-92. PubMed ID: 11729014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical issues in the long-term treatment of panic disorder.
    Rosenbaum JF; Pollack MH; Pollock RA
    J Clin Psychiatry; 1996; 57 Suppl 10():44-8; discussion 49-50. PubMed ID: 8917131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
    Mavissakalian MR; Perel JM
    Arch Gen Psychiatry; 1999 Sep; 56(9):821-7. PubMed ID: 12884888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder.
    Liebowitz MR; Asnis G; Mangano R; Tzanis E
    J Clin Psychiatry; 2009 Apr; 70(4):550-61. PubMed ID: 19358784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.
    Dannon PN; Iancu I; Lowengrub K; Gonopolsky Y; Musin E; Grunhaus L; Kotler M
    Clin Neuropharmacol; 2007; 30(6):326-34. PubMed ID: 18090457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sertraline treatment of panic disorder: response in patients at risk for poor outcome.
    Pollack MH; Rapaport MH; Clary CM; Mardekian J; Wolkow R
    J Clin Psychiatry; 2000 Dec; 61(12):922-7. PubMed ID: 11206597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New treatment options for panic disorder: clinical trials from 2000 to 2010.
    Freire RC; Hallak JE; Crippa JA; Nardi AE
    Expert Opin Pharmacother; 2011 Jun; 12(9):1419-28. PubMed ID: 21342080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.
    Pollack MH; Rapaport MH; Fayyad R; Otto MW; Nierenberg AA; Clary CM
    J Psychiatr Res; 2002; 36(4):229-36. PubMed ID: 12191627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic idiopathic urticaria associated with panic disorder: a syndrome responsive to selective serotonin reuptake inhibitor antidepressants?
    Gupta MA; Gupta AK
    Cutis; 1995 Jul; 56(1):53-4. PubMed ID: 7555104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of newer antidepressants for panic disorder.
    Gorman JM
    J Clin Psychiatry; 1997; 58 Suppl 14():54-8; discussion 59. PubMed ID: 9418747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The management of panic disorder.
    Sheehan DV
    J Clin Psychiatry; 2002; 63 Suppl 14():17-21. PubMed ID: 12562114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term management of major depressive disorder: are differences among antidepressant treatments meaningful?
    Shelton CI
    J Clin Psychiatry; 2004; 65 Suppl 17():29-33. PubMed ID: 15600379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressants in panic disorder: clinical and preclinical mechanisms.
    Nutt DJ
    J Clin Psychiatry; 1998; 59 Suppl 8():24-8; discussion 29. PubMed ID: 9707159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzodiazepines versus antidepressants for panic disorder.
    Kline NA
    Am J Psychiatry; 2004 Jul; 161(7):1312. PubMed ID: 15229080
    [No Abstract]   [Full Text] [Related]  

  • 35. Risks and benefits of medications for panic disorder: a comparison of SSRIs and benzodiazepines.
    Quagliato LA; Freire RC; Nardi AE
    Expert Opin Drug Saf; 2018 Mar; 17(3):315-324. PubMed ID: 29357714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Illness risk following rapid versus gradual discontinuation of antidepressants.
    Baldessarini RJ; Tondo L; Ghiani C; Lepri B
    Am J Psychiatry; 2010 Aug; 167(8):934-41. PubMed ID: 20478876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-year medication prophylaxis in panic disorder: to continue or discontinue? A naturalistic study.
    Choy Y; Peselow ED; Case BG; Pressman MA; Luff JA; Laje G; Paizis M; Ying P; Guardino MT
    Compr Psychiatry; 2007; 48(5):419-25. PubMed ID: 17707249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis.
    Boyer W
    Int Clin Psychopharmacol; 1995 Mar; 10(1):45-9. PubMed ID: 7622804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How often do SSRIs and other new-generation antidepressants lose their effect during continuation treatment? Evidence suggesting the rate of true tachyphylaxis during continuation treatment is low.
    Zimmerman M; Thongy T
    J Clin Psychiatry; 2007 Aug; 68(8):1271-6. PubMed ID: 17854252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placebo response in the treatment of panic disorder.
    Hirschfeld RM
    Bull Menninger Clin; 1996; 60(2 Suppl A):A76-86. PubMed ID: 8857428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.